Predictive Factors of the Use of Systemic Therapy in Stage IV Colorectal Cancer: Who Gets Chemotherapy?

Publisher： Karger

E-ISSN： 1423-0232|88|5|289-297

ISSN： 0030-2414

Source： Oncology, Vol.88, Iss.5, 2015-01, pp. : 289-297

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Distinctive oncological features of stage IIIA colorectal cancer: Analysis of prognostic factors for selective adjuvant chemotherapy

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 7, 2015-06 ,pp. : 882-890

John Wiley & Sons Inc

Access to resources Recommend Favorite

Predicting Chemotherapy Response to Paclitaxel-Based Therapy in Advanced Non-Small-Cell Lung Cancer (Stage IIIb or IV) with a Higher T Stage (> T2)

By  

Oncology, Vol. 63, Iss. 2, 2002-09 ,pp. : 173-179

Karger

Access to resources Recommend Favorite

Predictive Factors for Response to Neoadjuvant Therapy in Breast Cancer

By  

Oncology Research and Treatment, Vol. 37, Iss. 10, 2014-09 ,pp. : 563-568

Karger

Access to resources Recommend Favorite

Trends and predictors of resection of the primary tumor for patients with stage IV colorectal cancer

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 7, 2015-06 ,pp. : 911-916

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinicopathological Features and Predictive Factors for Colorectal Cancer Outcome in the Kingdom of Saudi Arabia

By  

Oncology, Vol. 92, Iss. 2, 2016-12 ,pp. : 75-86

Karger

Access to resources Recommend Favorite